vTv Therapeutics Inc.
NASDAQ:VTVT
14 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||
Net Income
| -20.25 | -25.073 | -17.731 | -12.802 | -21.938 | -23.845 | -54.647 | -55.353 | -41.107 | -36.101 | -48.203 |
Depreciation & Amortization
| 0.09 | 0.092 | 0.089 | 0.094 | 0.039 | 0.218 | 0.197 | 0.265 | 0.501 | 0.864 | 1.086 |
Deferred Income Tax
| -3 | 0 | 0 | -3.975 | -1.115 | 0.626 | 0.179 | -0.002 | 0.038 | 0 | 0.862 |
Stock Based Compensation
| 1.578 | 1.272 | 2.356 | 1.009 | 1.518 | 2.676 | 3.645 | 2.641 | 0.859 | 0 | 2.921 |
Change In Working Capital
| 4.394 | 5.385 | 0.035 | -2.706 | -2.054 | -7.545 | 5.037 | 4.086 | 2.041 | -1.684 | -8.821 |
Accounts Receivables
| 0.071 | -0.116 | 0.101 | -0.153 | -0.005 | 8 | -8 | 0.069 | -0.069 | -0.733 | 0.003 |
Inventory
| 0 | 0 | -0.889 | -1.976 | 0.618 | 0 | 0.194 | -0.359 | 0.547 | 0 | 0 |
Accounts Payables
| 2.929 | -0.856 | 1.828 | -0.997 | -0.618 | -6.199 | 2.448 | 4.786 | 2.93 | 0 | 0 |
Other Working Capital
| 1.394 | 6.357 | -1.005 | 0.42 | -2.049 | -15.545 | 10.395 | -0.41 | -1.367 | -0.951 | -8.824 |
Other Non Cash Items
| -1.327 | 2.302 | -4.057 | 0.38 | 0.532 | 1.014 | 1.029 | 0.154 | 0.722 | 6.142 | 10.471 |
Operating Cash Flow
| -18.515 | -16.022 | -19.308 | -18 | -23.018 | -26.856 | -44.56 | -48.209 | -36.946 | -30.779 | -41.684 |
Investing Activities: | |||||||||||
Investments In Property Plant And Equipment
| 0 | -0.021 | 0 | 0 | -0.07 | -0.005 | -0.057 | -0.087 | -0.104 | -0.033 | -0.181 |
Acquisitions Net
| 4.404 | 0 | 0 | 0 | 0.312 | 0.012 | 0.032 | 0.004 | 0.025 | -0.14 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 4.404 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| -4.404 | 0 | 0 | 0 | 0.312 | 0.012 | 0.032 | 0.004 | 0.025 | 0.334 | 0.025 |
Investing Cash Flow
| 4.404 | -0.021 | 0 | 0 | 0.242 | 0.007 | -0.025 | -0.083 | -0.079 | 0.161 | -0.156 |
Financing Activities: | |||||||||||
Debt Repayment
| -0.033 | -0.808 | -0.715 | -5.456 | -10.573 | -5.388 | -7.5 | -11.794 | -0.089 | -0.148 | -0.141 |
Common Stock Issued
| 12.03 | 5.04 | 26.757 | 24.426 | 32.943 | 21.5 | 0 | 0 | 105.773 | 0 | 0.011 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0.992 | 0 | 0.302 | 0.923 | 0 | -2.5 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 12.03 | 10.522 | 0.934 | 0.5 | 0.5 | 0.5 | 7.198 | 10.871 | 17.96 | 33.561 | 40.935 |
Financing Cash Flow
| 11.997 | 14.754 | 26.976 | 19.47 | 22.87 | 16.612 | 7.5 | 11.794 | 123.644 | 30.913 | 40.805 |
Other Information: | |||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -2.68 | -1.289 | 7.668 | 1.47 | 0.094 | -10.237 | -37.085 | -36.498 | 86.619 | 0.295 | -1.035 |
Cash At End Of Period
| 9.446 | 12.126 | 13.415 | 5.747 | 4.277 | 4.183 | 14.42 | 51.505 | 88.003 | 1.384 | 1.089 |